Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares were down 0.2% during trading on Tuesday . The stock traded as low as C$5.10 and last traded at C$5.23. Approximately 39,354 shares traded hands during mid-day trading, a decline of 19% from the average daily volume of 48,589 shares. The stock had previously closed at C$5.24.
Medexus Pharmaceuticals Stock Down 2.5%
The stock has a fifty day moving average of C$5.05 and a two-hundred day moving average of C$4.12. The stock has a market cap of C$160.27 million, a price-to-earnings ratio of -72.86 and a beta of 0.20.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
